Claims for Patent: 8,034,395

Summary for Patent: 8,034,395

Title:	Method for precipitating mono and multiple layers of organophosphoric and organophosphonic acids and the salts thereof in addition to use thereof
Abstract:	The invention relates to a method for precipitating mono or multiple layers of a mixture of organophosphoric acids of the general formula I (A) Y--B--OPO.sub.3H.sub.2 (IA) or of organophosphonic acids of the general formula I (B) Y--B--PO.sub.3H.sub.2 (IB) and the salts thereof, wherein Y and B are defined in the specification. According to the invention, precipitation occurs on substrate surfaces of pure or mixed oxides, nitrides or carbides of metals and semiconductors, in particular as surfaces of sensor platforms, implants and medical accessory devices. The invention also relates to the use thereof as part of coated sensor platforms, implants and medical accessory devices.
Inventor(s):	Hofer; Rolf (Dachsen, CH), Pawlak; Michael (Laufenburg, DE), Textor; Marcus (Schaffhausen, CH), Schurmann-Mader; Eveline (Zeihen, CH), Ehrat; Markus (Magden, CH), Tosatti; Samuele (Magliaso, CH)
Assignee:	Bayer Technology Services GmbH (Leverkusen, DE)
Application Number:	12/662,932
Patent Claims:	1. A method which comprises precipitating mono or multiple layers of a mixture of at least two different acids selected from the group consisting of organophosphoric acids of the general formula I (A) Y--B--OPO.sub.3H or of organophosphonic acids of the general formula I (B) Y--B--PO.sub.3H.sub.2 and the salts thereof, on a substrate surface of pure or mixed oxides, nitrides or carbides of metals or semiconductors, wherein B is an alkyl, alkenyl, alkinyl, aryl, aralkyl, hetaryl or hetarylalkyl residue and Y is hydrogen or a functional group from the hydroxy, carboxy, amino, optionally low-alkyl-substituted mono or dialkylamino series, thiol, or a negative acid group from the ester, phosphate, phosphonate, sulfate, sulfonate, maleimide, succinirnydyl, epoxy, acrylate series, wherein a biological, biochemical or synthetic recognition element is coupled to B or Y by addition or substitution reaction, wherein compounds may also be added conferring on the substrate surface a resistance to protein adsorption and/or to cell adhesion and the B chain may optionally be comprised of one or more ethylene oxide groups, rather than one or more --CH2-groups, and wherein the organophosphoric acid or organophosphonic acid is precipitated from water-soluble salts of a compound of formula (IA) or (IB) for the treatment of these surfaces, of sensor platforms, implants and medical accessory devices, and wherein the biochemical, biological or synthetic recognition elements (coupled to B or Y) are selected from among the group of nucleic acids, such as DNA, RNA, oligonucleotides, nucleic acid analogs, such as PNA, monoclonal or polyclonal antibodies, peptides, enzymes, aptamers, synthetic peptide structures, soluble membrane-bound proteins and proteins isolated from a membrane, such as receptors, ligands thereof, antigens for antibodies, biotin, "histidine tag components" and complexing partners thereof. 2. A method according to claim 1 which comprises controlling the hydrophilicity or hydrophobicity of the surface by selecting the ratio of the mixture. 3. A method according to claim 1 comprising the possibility of adjusting a controlled density of positive and/or negative charges on the surface by selecting the ratio of the mixture. 4. A method according to claim 1 comprising the possibility of adjusting a controlled density of reactive groups and/or biochemical recognition elements or biological "functions" by selecting the ratio of the mixture. 5. A method which comprises precipitating mono or multiple layers of a mixture of at least two different acids selected from the group consisting of organophosphoric acids of the general formula I (A) Y--B--OPO.sub.3H or of organophosphonic acids of the general formula I (B) Y--B--PO.sub.3H.sub.2 and the salts thereof, on a substrate surface of pure or mixed oxides nitrides or carbides of metals or semiconductors, wherein B is an alkyl, alkenyl, alkinyl, aryl, aralkyl, hetaryl or hetarylalkyl residue and Y is hydrogen or a functional group from the hydroxy, carboxy, amino, optionally low-alkyl-substituted mono or dialkylamino series, thiol, or a negative acid group from the ester, phosphate, phosphonate, sulfate, sulfonate, maleimide, succinimydyl, epoxy, acrylate series, wherein a biologically effective recognition element is coupled to B or Y by addition or substitution reaction, wherein compounds may also be added conferring on the substrate surface a resistance to protein adsorption and/or to cell adhesion and the B chain may optionally be comprised of one or more ethylene oxide groups, rather than one or more --CH2- groups, and wherein the organophosphoric acid or organophosphonic acid is precipitated from water-soluble salts of a compound of formula (IA) or (IB) for the treatment of these surfaces, of sensor platforms, implants and medical accessory devices, and wherein the biologically effective recognition element comprises peptides, proteins, glycoproteins, growth factor, such as TGF-.beta., or BMP (bone morphogenic protein). 6. A method which comprises precipitating mono or multiple layers of a mixture of at least two different acids selected from the group consisting of organophosphoric acids of the general formula I (A) Y--B--OPO.sub.3H or of organophosphonic acids of the general formula I (B) Y--B--PO.sub.3H.sub.2 and the salts thereof, on a substrate surface of pure or mixed oxides, nitrides or carbides of metals or semiconductors, wherein B is an alkyl, alkenyl, alkinyl, aryl, aralkyl, hetaryl or hetarylalkyl residue and Y is hydrogen or a functional group from the hydroxy, carboxy, amino, optionally low-alkyl-substituted mono or dialkylamino series, thiol, or a negative acid group from the ester, phosphate, phosphonate, sulfate, sulfonate, maleimide, succinimydyl, epoxy, acrylate series, wherein a biological, biochemical or synthetic indicator element may be coupled to B or Y by addition or substitution reaction, wherein compounds are also added conferring on the substrate surface a resistance to protein adsorption and/or to cell adhesion and the B chain may optionally be comprised of one or more ethylene oxide groups, rather than one or more --CH2- groups, and wherein the organophosphoric acid or organophosphonic acid is precipitated from water-soluble salts of a compound of formula (IA) or (IB) for the treatment of these surfaces, of sensor platforms, implants and medical accessory devices, and wherein the compounds which confer on the substrate surface a resistance to protein adsorption and/or to cell adhesion are selected from the group of compounds which are formed from oligo(ethylene oxide), phosphoryl choline, heparin, saccharides, albumins, especially bovine serum albumin or human serum albumin, casein, nonspecific, polyclonal or monoclonal, heterologous or for the analyte or analytes to be determined empirically nonspecific antibodies (especially for immunoassays), detergents (such as Tween 20), fragmented natural DNA or synthetic DNA not hybridizing with polynucleotides for analysis, such as a herring or salmon sperm extract (especially for polynucleotide hybridization assays), or also uncharged, but hydrophilic polymers, such as polyethylene glycols or dextrans. 7. A method which comprises precipitating mono or multiple layers of a mixture of at least two different acids selected from the group consisting of organophosphoric acids of the general formula I (A) Y--B--OPO.sub.3H or of organophosphonic acids of the general formula I (B) Y--B--PO.sub.3H.sub.2 and the salts thereof, on a substrate surface of pure or mixed oxides, nitrides or carbides of metals or semiconductors, wherein B is an alkyl, alkenyl, alkinyl, aryl, aralkyl, hetaryl or hetarylalkyl residue and Y is hydrogen or a functional group from the hydroxy, carboxy, amino, optionally low-alkyl-substituted mono or dialkylamino series, thiol, or a negative acid group from the ester, phosphate, phosphonate, sulfate, sulfonate, maleimide, succinimydyl, epoxy, acrylate series, wherein a biological, biochemical or synthetic recognition element is coupled to B or Y by addition or substitution reaction, wherein compounds are, also added conferring on the substrate surface a resistance to protein adsorption and/or to cell adhesion in a SAM molecule and the B chain may optionally be comprised of one or more ethylene oxide groups, rather than one or more --CH2- groups, and wherein the organophosphoric acid or organophosphonic acid is precipitated from water-soluble salts of a compound of formula (IA) or (IB) for the treatment of these surfaces, of sensor platforms, implants and medical accessory devices. 8. A sensor platform having a surface of a mono or multiple layers of a mixture of at least two different acids selected from the group consisting of organophosphates and/or organophosphonates. 9. A sensor platform according to claim 8 comprising at least one array of biological or biochemical or synthetic recognition elements, immobilized in discrete measurement areas (d) for the specific recognition and/or binding of one or more analytes and/or specific interaction with said analytes. 10. A sensor platform according to claim 8 capable of detection of one or more analytes by means of labels selected from the group consisting of luminescence labels, especially luminescent intercalators or "molecular beacons", absorption labels, mass labels, especially metal colloids or plastic beads, spin labels, such as ESR or NMR labels, and radioactive labels. 11. A sensor platform according to claim 9 capable of detection of analyte based on the determination of a change in the effective refractive index as a result of molecular adsorption or desorption on the measurement areas (d). 12. A sensor platform according to claim 11 capable of detection of analyte based on determination of a change in conditions for generating a surface plasmon in a metal layer of a multiple layer system, wherein the metal layer preferably comprises gold or silver. 13. A sensor platform according to claim 9 capable of detection of analyte based on the determination of a change in one or more luminescences. 14. A sensor platform according to claim 13 capable of delivery of excitation light in a vertical illuminator. 15. A sensor platform according to claim 9, wherein material of the sensor platform that is in contact with the measurement areas is transparent or absorbent within a depth of at least 200 nm from the measurement areas in at least one excitation wavelength. 16. A sensor platform according to claim 14, wherein the delivery of the excitation light is in a transmission configuration. 17. A sensor platform according to claim 16, wherein material of the sensor platform is transparent in at least one excitation wavelength. 18. A sensor platform according to claim 8 formed as an optical waveguide which is preferably essentially planar. 19. A sensor platform according to claim 8 which comprises an optically transparent material selected from the group of silicates, e.g. glass or quartz, transparent thermoplastic or moldable plastic, for example polycarbonate, polyimide, acrylates, especially polymethylmethacrylate, and polystyrene. 20. A sensor platform according to claim 8 which comprises an optical thin-layer waveguide with a layer which is transparent in at least one excitation wavelength (a) on a layer which is likewise transparent in at least this excitation wavelength (b) with a lower refractive index than layer (a). 21. A sensor platform according to claim 8, wherein the mono or multiple layers was precipitated on a substrate surface of pure or mixed oxides, nitrides or carbides of metals or semiconductors. 22. A sensor platform according to claim 21, wherein the substrate surface shows a defined pattern with silicon dioxide or transition metal oxide. 23. A sensor platform according to claim 22, wherein the mono or multiple payers are precipitated on the silicon dioxide areas. 24. A sensor platform according to claim 8, wherein the mono or multiple layers was precipitated on a substrate surface, preferably in a local selective manner, using a method selected from the group comprising immersion, spreading, brushing, inkjet spotting, mechanical spotting by means of a stylus, pen or capillary, micro-contact-printing, fluidic contact of the substrate surface with parallel or crossed micro-channels under the influence of pressure differences or electrical or electromagnetic potentials. 25. A sensor platform according to claim 8 comprising local hydrophilic or hydrophobic areas being produced by local precipitation of the mono or multiple layers on a substratesurfaces of pure or mixed oxides, nitrides or carbides of metals or semi-conductors and their surrounding substrate surface then being coated with a terminally hydrophobic or hydrophilic monolayer. 26. A method according to claim 1, wherein the mono or multiple layers of a mixture of at least two different acids selected from the group consisting of compounds of formula (IA) and/or (IB) are free of organic solvents. 27. A method according to claim 1, wherein the water soluble salts of a compound of formula (IA) or (IB) are sodium, potassium and/or ammonium salts. 28. A method according to claim 1, wherein the pure or mixed oxides, nitrides or carbides of metals are solid bodies or layers on substrates of any kind and the metals are selected from the group consisting of tantalum, niobium, titanium, vanadium, zirconium, hafnium, molybdenum, tungsten, silicon and mixtures thereof. 29. A method according to claim 5, wherein the mono or multiple layers of a mixture of at least two different acids selected from the group consisting of compounds of formula (IA) and/or (IB) are free of organic solvents. 30. A method according to claim 5, wherein the water soluble salts of a compound of formula (IA) or (IB) are sodium, potassium and/or ammonium salts. 31. A method according to claim 5, wherein the pure or mixed oxides, nitrides or carbides of metals are solid bodies or layers on substrates of any kind and the metals are selected from the group consisting of tantalum, niobium, titanium, vanadium, zirconium, hafnium, molybdenum, tungsten, silicon and mixtures thereof. 32. A method according to claim 5 which comprises controlling the hydrophilicity or hydrophobicity of the surface by selecting the ratio of the mixture. 33. A method according to claim 5 comprising the possibility of adjusting a controlled density of positive and/or negative charges on the surface by selecting the ratio of the mixture. 34. A method according to claim 5 comprising the possibility of adjusting a controlled density of reactive groups and/or biochemical recognition elements or biological "functions" by selecting the ratio of the mixture. 35. A method according to claim 6, wherein the mono or multiple layers of a mixture of at least two different acids selected from the group consisting of compounds of formula (IA) and/or (IB) are free of organic solvents. 36. A method according to claim 6, wherein the watersoluble salts of a compound of formula (IA) or (IB) are sodium, potassium and/or ammonium salts. 37. A method according to claim 6, wherein the pure or mixed oxides, nitrides or carbides of metals are solid bodies or layers on substrates of any kind and the metals are selected from the group consisting of tantalum, niobium, titanium, vanadium, zirconium, hafnium, molybdenum, tungsten, silicon and mixtures thereof. 38. A method according to claim 6 which comprises controlling the hydrophilicity or hydrophobicity of the surface by selecting the ratio of the mixture. 39. A method according to claim 6 comprising the possibility of adjusting a controlled density of positive and/or negative charges on the surface by selecting the ratio of the mixture. 40. A method according to claim 6 comprising the possibility of adjusting a controlled density of reactive groups and/or biochemical recognition elements or biological "functions" by selecting the ratio of the mixture. 41. A method according to claim 7, wherein the mono or multiple layers of a mixture of at least two different acids selected from the group consisting of compounds of formula (IA) and/or (IB) are free of organic solvents. 42. A method according to claim 7, wherein the watersoluble salts of a compound of formula (IA) or (IB) are sodium, potassium and/or ammonium salts. 43. A method according to claim 7, wherein the pure or mixed oxides, nitrides or carbides of metals are solid bodies or layers on substrates of any kind and the metals are selected from the group consisting of tantalum, niobium, titanium, vanadium, zirconium, hafnium, molybdenum, tungsten, silicon and mixtures thereof. 44. A method according to claim 7 which comprises controlling the hydrophilicity or hydrophobicity of the surface by selecting the ratio of the mixture. 45. A method according to claim 7 comprising the possibility of adjusting a controlled density of positive and/or negative charges on the surface by selecting the ratio of the mixture. 46. A method according to claim 7 comprising the possibility of adjusting a controlled density of reactive groups and/or biochemical recognition elements or biological "functions" by selecting the ratio of the mixture. 47. An implant of metal or ceramic having a surface of a monolayer of organophosphates and/or organophosphonates or of a mixture of at least two different acids selected from the group consisting of organophosphates and/or organophosphonates. 48. An implant according to claim 47 with implants from oxide-coated metals such as titanium, tantalum, niobium, alloys such as titanium-aluminium-vanadium, titanium-aluminium-niobium, titanium-niobium-zirconium, titanium-niobium-zirconium-tantalum, cobalt-chromium, cobalt-chromium-molybdenum, iron-nickel-chromium. 49. An implant according to claim 48 comprising the implant being selected from the group of root implants for dental applications, artificial prostheses, such as hip joint stems, balls and sockets, artificial knee joints, osteosynthesis components, such as bone plates, screws, "fixateur exteme", components for the repair of damage in the cranial region ("maxillofacial devices"), components in the field of spinal surgery ("spinal surgery implants"), stents, and cardiac pacemaker components. 50. Medical accessory devices of metal or ceramic having a surface of a monolayer of organophosphates and/or organophosphonates or of a mixture of at least two different acids selected from the group consisting of organophosphates and/or organophosphonates. 51. Medical accessory devices of metal or ceramic according to claim 50, wherein these accessory devices are selected from the group comprising catheters, balloon catheters, endoscopes, components for exogenous, blood-carrying systems, such as cardiovascular machines.

Details for Patent 8,034,395

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Grifols Therapeutics Llc	ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5	albumin (human)	For Injection	101138	10/21/1942		2020-09-05
Baxalta Us Inc.	BUMINATE, FLEXBUMIN	albumin (human)	Injection	101452	03/03/1954		2020-09-05
Csl Behring Ag	ALBURX	albumin (human)	Injection	102366	07/23/1976		2020-09-05
Grifols Biologicals Llc	ALBUTEIN	albumin (human)	Injection	102478	08/15/1978		2020-09-05
Instituto Grifols, S.a.	HUMAN ALBUMIN GRIFOLS	albumin (human)	Injection	103352	02/17/1995		2020-09-05
Instituto Grifols, S.a.	HUMAN ALBUMIN GRIFOLS	albumin (human)	Injection	103352	06/11/2003		2020-09-05